The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Market Value Is Expected For The Single-Chamber Prefilled Syringes Market At The End Of The 2026–2030 Forecast Period?
The single-chamber prefilled syringes market has seen rapid expansion in recent years. Its valuation is set to increase from $11.97 billion in 2025 to $13.93 billion in 2026, achieving a compound annual growth rate (CAGR) of 16.4%. This past growth can be ascribed to several factors including the rise in injectable drug formulations, expanding vaccination programs, the proliferation of biologics manufacturing, an increased emphasis on patient safety standards, and the introduction of advanced packaging materials.
The single-chamber prefilled syringes market is projected to experience substantial expansion in the coming years. By 2030, its valuation is anticipated to reach $25.79 billion, demonstrating a compound annual growth rate (CAGR) of 16.7%. This expected growth over the forecast period stems from several factors, including a heightened demand for injectables that can be self-administered, an expanding pipeline for biologics, an increase in medication delivery within home settings, a greater emphasis on sustainable packaging, and the wider embrace of prefilled syringes in developing markets. Concurrently, significant developments anticipated during this period encompass the growing integration of prefilled drug delivery solutions, a rising need for injectable formats that are ready-to-use, an increased reliance on plastic-based syringe components, the broadening of applications for vaccine and biologic packaging, and a sharper focus on ensuring precise dosing and patient well-being.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=5419&type=smp
Which Market Drivers Are Supporting The Expansion Of The Single-Chamber Prefilled Syringes Market?
The increasing incidence of chronic conditions like diabetes and cancer is fueling expansion within the single-chamber prefilled syringe market. Patients with diabetes who need insulin therapy, particularly when oral medications fail to manage their blood glucose, utilize single-chamber prefilled syringes. This rise in chronic diseases, including diabetes and cancer, largely stems from increasingly inactive lifestyles, which disturb metabolic equilibrium and diminish long-term physiological robustness, thereby increasing the susceptibility to chronic ailments. These single-chamber prefilled syringes assist in managing chronic conditions like diabetes and cancer by facilitating quick, precise, and convenient administration of injectable treatments, enhancing patient adherence, and minimizing dosing mistakes over extended care periods. For illustration, data from February 2024, released by the World Health Organization, a Switzerland-based specialized agency dedicated to international public health, indicates that by 2050, more than 35 million new cancer cases are anticipated, marking a 77% rise from the approximately 20 million cases recorded in 2022. Consequently, the expanding occurrence of chronic illnesses such as diabetes and cancer acts as a primary market driver for single-chamber prefilled syringes.
What Segment Types Make Up The Single-Chamber Prefilled Syringes Market?
The single-chamber prefilled syringes market covered in this report is segmented –
1) By Type: Glass, Plastic
2) By Application: Vaccine Product, Biologic, Pharmaceutical Product
3) By End-User: Hospitals And Clinics, Ambulatory Care Centers And Specialty Clinics, Home Healthcare And Self-Administration
Subsegments:
1) By Glass: Borosilicate Glass Syringes, Type I Glass Syringes, Type II Glass Syringes
2) By Plastic: Polypropylene Syringes, Polycarbonate Syringes, Cyclo-olefin Polymer Syringes
Which Market Trends Are Creating New Opportunities In The Single-Chamber Prefilled Syringes Market?
Major companies operating in the Single-Chamber Prefilled Syringes market are concentrating on creating advanced polymer-based single-dose prefilled syringe systems. This effort aims to satisfy the growing need for scalable, economical, and secure injectable delivery options, which is spurred by the increased adoption of biologics and self-administration at home. Polymer prefilled syringes, fabricated from materials such as cyclic-olefin polymer (COP) or cyclic-olefin copolymer (COC), offer superior drug stability and inertness, alongside a reduced likelihood of breakage compared to conventional glass syringes. For example, in January 2023, Sharps Technology, Inc., a U.S.-based medical device and pharmaceutical-packaging company, declared its plan to launch next-generation specialty polymer prefillable syringe systems, manufactured in collaboration with Nephron Pharmaceuticals using COP and COC materials. These sophisticated syringes are engineered to decrease contamination, reduce dead space, and remove the risk of breakage, all while remaining compatible with current fill-finish lines. Furthermore, they are free of silicon to mitigate aggregation risk, enhancing their safety and reliability. This information is sourced from a Sharps Technology press release.
Who Are The Key Players Driving Competition In The Single-Chamber Prefilled Syringes Market?
Major companies operating in the single-chamber prefilled syringes market are Becton Dickinson and Company, Gerresheimer Glass Inc., Schott AG, Catalent Inc., Nipro Medical Corporation, Weigao Group Medical Polymer Company Limited, Stevanato Group S.p.A., Baxter International Inc., Vetter Pharma International GmbH, Terumo Corporation, Ypsomed Holding AG, SHL Medical AG, Ompi, Elcam Medical A.C.S. Ltd., Oval Medical Technologies Ltd., West Pharmaceutical Services Inc., Gerresheimer Regensburg GmbH, SCHOTT North America Inc., Vetter Pharma-Fertigung GmbH & Co. KG, Aptar Pharma Services Inc., Bespak Europe Ltd., Credence MedSystems Inc., Datwyler Pharma Packaging International Holding AG, Dätwyler Sealing Solutions AG, Fresenius Kabi AG, Haselmeier GmbH, Hikma Pharmaceuticals PLC, HTL-STREFA S.A., Intas Pharmaceuticals Ltd.
Read the full single-chamber prefilled syringes market report here:
How Is The Single-Chamber Prefilled Syringes Market Distributed Across Key Geographic Regions?
North America was the largest region in the single-chamber prefilled syringes market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the single-chamber prefilled syringes market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Single-Chamber Prefilled Syringes Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=5419&type=smp
Browse Through More Reports Similar to the Global Single-Chamber Prefilled Syringes Market 2026, By The Business Research Company
Pre Filled Syringes Market Report 2026
https://www.thebusinessresearchcompany.com/report/pre-filled-syringes-global-market-report
Disposable Syringes Market Report 2026
https://www.thebusinessresearchcompany.com/report/disposable-syringes-global-market-report
Syringe Trays Market Report 2026
https://www.thebusinessresearchcompany.com/report/syringe-trays-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model